Strengthening of Harm Reduction Response to Injecting of Drugs in Lithuania: Benefits from Participation in an EU Joint Action Project HAREACT
Vilnius Center for Addictive Disorders, Vilnius, Lithuania, May 3-6, 2017
Keynote Speaker: Emilis Subata
EU Joint Action on HIV and co-infection prevention and harm reduction (“HAREACT”) continues from October 2015 until September 2018. Twenty-three partners (organizations) from 18 European countries joined the project. The project has a budget 3.75 m EUR and EU co-funds project by 80%. National Institute for Health and Welfare (THL), Finland coordinates the project. The project focus group are people who inject mainly opioids and stimulants. The evidence-based policies, access to evidence based interventions, such as medical care and social reintegration for this group, integrated services for co-morbid patients with HIV, viral hepatitis, TB and STI are present in the region. Much of the activities of the project aims at strengthening of sustainable policies and response to drug consumption and prevention of infectious diseases in three focus countries of the project (Hungary, Latvia and Lithuania) and across EU.